GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Total Debt History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Debt | - | - | ₹0.02 Cr | ₹0.18 Cr | ₹0.58 Cr |
What is the latest Total Debt ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
Year | Total Debt |
---|---|
Mar2023 | - |
Mar2022 | - |
Mar2021 | ₹0.02 Cr |
Mar2020 | ₹0.18 Cr |
Mar2019 | ₹0.58 Cr |
How is Total Debt of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
Years | Total Debt | % Change | |
---|---|---|---|
Mar2023 | - | 0 | |
Mar2022 | - | -100.00 | |
Mar2021 | ₹0.02 Cr | -86.44 | |
Mar2020 | ₹0.18 Cr | -69.64 | |
Mar2019 | ₹0.58 Cr | - |
Compare Total Debt of peers of GLAXOSMITHKLINE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAXOSMITHKLINE PHARMACEUTICALS | ₹41,171.0 Cr | 8% | 27.4% | 84.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹356,673.0 Cr | -2.4% | 0.8% | 66.3% | Stock Analytics | |
CIPLA | ₹119,930.0 Cr | 6.4% | 10.5% | 61.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹109,446.0 Cr | 5.1% | 9% | 31.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹108,261.0 Cr | 3.2% | 13.1% | 117.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,830.6 Cr | 1.6% | -1% | 33.8% | Stock Analytics |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAXOSMITHKLINE PHARMACEUTICALS | 8% |
27.4% |
84.5% |
SENSEX | 2% |
2.3% |
22.2% |
You may also like the below Video Courses